Autonomix Medical (AMIX) Convertible Debt (2024)

Autonomix Medical (AMIX) posted quarterly Convertible Debt of $1.1 million for Q3 2024, up 4.12% quarter-over-quarter from $1.0 million in Q2 2024.

Autonomix Medical (AMIX) Convertible Debt (2024) Analysis & Trends

Autonomix Medical (AMIX) has reported Convertible Debt for 1 consecutive years, with $1.1 million the latest figure, recorded in Q3 2024.

In Q3 2024, Convertible Debt changed N/A year-over-year to $1.1 million; the TTM figure through Sep 2024 stood at $1.1 million (changed N/A YoY), while the FY2024 annual figure was $1.0 million, changed N/A from the prior year.
Convertible Debt grew to $1.1 million in Q3 2024 per AMIX's latest filing, from $1.0 million in the prior quarter.
Across five years, Convertible Debt topped out at $1.1 million in Q3 2024 and bottomed at $1.0 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.43 Bn	193.83 Bn	7.27 Bn
2	Stryker	125.99 Bn	122.51 Bn	4.50 Bn
3	Medtronic	118.19 Bn	108.97 Bn	6.41 Bn
4	Boston Scientific	72.95 Bn	72.41 Bn	3.85 Bn
5	Edwards Lifesciences	51.75 Bn	47.50 Bn	1.35 Bn
6	Dexcom	34.45 Bn	32.50 Bn	830.00 Mn
7	GE HealthCare Technologies	33.58 Bn	31.47 Bn	2.18 Bn
8	Koninklijke Philips	26.07 Bn	22.75 Bn	4.55 Bn
9	Steris	23.07 Bn	22.58 Bn	684.20 Mn
10	Autonomix Medical	2.34 Mn	-4.66 Mn	-

Download Data